Abstract
One in 3 people aged > 75 years develops age-related macular degeneration (AMD), the leading cause of blindness among middle-aged and elderly people. However, the current ‘gold standard’ of laser surgery benefits only a few patients, who risk suffering serious adverse effects. But promising results with photodynamic therapy announced at the meeting of the European Society of Ophthalmology [ Stockholm, Sweden; June 1999 ] should transform the prospects for people who develop this debilitating disease.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Greener, M. New light on macular degeneration. Inpharma Wkly. 1199, 10–11 (1999). https://doi.org/10.2165/00128413-199911990-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199911990-00014